Article thumbnail

Advances and Developments in the Use of Human Mesenchymal Stem Cells – A Few Considerations

By Lucinda Kennard, Gopiga Thanabalasundaram, Hiteshkumar D Tailor and Wasim S Khan


One less visited area in musculoskeletal stem cell research is the effects of donor age on quality of stem cells. The prevalence of degenerative orthopaedic conditions is large, and the older population is likely to receive great benefit from stem cell therapies. There are many known growth factors involved in controlling and influencing stem cell growth which are also related to cell senescence. Of which, expressions are found to be altered in mesenchymal stem cells from older donors. Considerations must also be taken of these mechanisms which also have a role in cell cycle and tumour suppression

Topics: Article
Publisher: Bentham Open
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2011). A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell
  2. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev
  3. (2008). Age-Related Intrinsic Changes in Human Bone Marrow-Derived Mesenchymal Stem Cells and Their Differentiation to Osteoblasts. Aging Cell
  4. (1999). Agerelated osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res
  5. (2006). Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells.
  6. (2011). Effects of Donor Age, Gender, and In Vitro Cellular Aging on the Phenotypic, Functional, and Molecular Characteristics of Mouse Bone MarrowDerived Mesenchymal Stem Cells. Stem Cells Dev
  7. (1988). Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages.
  8. (2007). Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells
  9. (2011). Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential Stem Cells Int
  10. (2010). Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.
  11. (2008). FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.
  12. (2009). Human adipose-derived stem cells isolated from young and elderly women: their differentiation potential and scaffold interaction during in vitro osteoblastic differentiation. Cytotherapy
  13. (2011). Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev [Internet].
  14. (1995). Influence of age on human marrow. Calcif Tissue Int
  15. (2009). Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells. Exp Gerontol
  16. (2010). miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology
  17. (2011). MITR is a swith that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating PPAR{gamma}-2. J Biol Chem [Internet].
  18. (2011). Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. Atherosclerosis
  19. (2000). Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow.
  20. (2000). Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA
  21. (2007). Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell
  22. (2008). Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE
  23. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell
  24. (2009). Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways. Stem Cells
  25. (2009). Small silencing RNAs: an expanding universe. Nat Rev Genet
  26. (2002). Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol
  27. (2010). The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res
  28. (2009). The epitope characterisation and the osteogenic differentiation potential of human fat pad-derived stem cells is maintained with ageing in later life. Injury
  29. (2011). The Low-dose Ionizing Radiation Stimulates Cell Proliferation via Activation of the MAPK/ERK Pathway in Rat Cultured Mesenchymal Stem Cells.
  30. (2010). The role of PPAR for the osteoblastic differentiation.
  31. (1961). The serial cultivation of human diploid cell strains.